N. Karvounis

Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial

D. Pectasides, John Glotsos, N Bountouroglou et al. · Annals of Oncology · 2002 · 59 citations · Full text

Medicine, Oncology, Pharmacology +8

A randomized trial of the effect of three non‐steroid antiinflammatory agents in ameliorating cancer‐induced fever

N. Tsavaris, Andreas Zinelis, A. Karabelis et al. · Journal of Internal Medicine · 1990 · 56 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

Aristides Polyzos, Nikolaos Malamos, Ioannis Boukovinas et al. · Breast Cancer Research and Treatment · 2009 · 43 citations · Full text

Medicine, Oncology, Pharmacology +14

Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

Christos Kosmas, N. Mylonakis, Georgios Tsakonas et al. · British Journal of Cancer · 2009 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

Combination Chemotherapy With Carboplatin, Docetaxel, and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase II Study

D. Pectasides, A. Aspropotamitis, A. Halikia et al. · Journal of Clinical Oncology · 1999 · 27 citations

Medicine, Oncology, Pharmacology +16